Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1986-1-21
pubmed:abstractText
The rate of insulin secretion from isolated rat islets of Langerhans was affected by a number of dihydropyridine derivatives known to interact with voltage-sensitive Ca2+ channels in excitable cells. The channel antagonists nifedipine and nitrendipine were potent inhibitors of glucose-induced insulin secretion in response to both 8 mM- and 20 mM-glucose, although they did not lower the basal secretion rate observed in the presence of 4 mM-glucose. The Ca2+-channel agonist, CGP 28392, also failed to alter the basal rate of insulin secretion. In the presence of 8 mM-glucose, however, 1 microM-CGP 28392 enhanced the insulin-secretion rate to a value approximately double that with 8 mM-glucose alone. This effect was dose-dependent, with half the maximal response elicited by 0.1 microM-CGP 28392, and full enhancement at 10 microM. The response was rapid in onset, with an increase in insulin secretion evident within 2 min of CGP 28392 infusion in perifused islets. Stimulation of insulin secretion by CGP 28392 was correlated with a rapid enhancement of glucose-stimulated 45Ca2+ uptake into islets cells, and with a transiently increased rate of 45Ca2+ efflux from pre-loaded islets. Stimulation of insulin secretion by CGP 28392 was abolished in the presence of noradrenaline, although under these conditions the rapid stimulation of 45Ca2+ influx induced by CGP 28392 was only partially inhibited. In contrast with these results, when islets were incubated in the presence of 20 mM-glucose, CGP 28392 caused a dose-dependent inhibition of insulin secretion. Half-maximal inhibition required approx. 0.2 microM-CGP 28392, with maximal effects observed at 10 microM. Under these conditions, however, the extent of insulin secretion was still only decreased by about 50%, to a value which was similar to that seen in the presence of 8 mM-glucose and CGP 28392. These results suggest that dihydropyridine derivatives can alter the activity of voltage-dependent Ca2+ channels in islet cells, and are consistent with the possibility that gating of these channels plays an important role in regulating the rate of insulin secretion after glucose stimulation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-1095720, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-2580242, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-2986600, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-2992453, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-324477, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-332717, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-336505, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-353076, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-369829, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-382870, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-3885954, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-4863806, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-4873864, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-4879533, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-5501260, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-5684032, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-5957483, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6093775, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6117094, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6190088, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6205402, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6206501, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6207438, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6207819, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6210203, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6277201, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6288009, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6292718, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6322768, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6373371, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6388655, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-6987115, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-7020702, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-767190, http://linkedlifedata.com/resource/pubmed/commentcorrection/2934056-792423
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
231
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
629-34
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't